Search Results - "FORSCHER, C"

Refine Results
  1. 1

    Hormone receptor expression in uterine sarcomas: Prognostic and therapeutic roles by Ioffe, Y.J, Li, A.J, Walsh, C.S, Karlan, B.Y, Leuchter, R, Forscher, C, Cass, I

    Published in Gynecologic oncology (01-12-2009)
    “…Abstract Objectives. The utility of hormone therapy in the management of uterine sarcomas is poorly defined. We hypothesize that estrogen receptor (ER)…”
    Get full text
    Journal Article
  2. 2

    Treatment-Induced Pathologic Necrosis: A Predictor of Local Recurrence and Survival in Patients Receiving Neoadjuvant Therapy for High-Grade Extremity Soft Tissue Sarcomas by EILBER, Fritz C, ROSEN, Gerald, ECKARDT, Jeffery, FORSCHER, Charles, NELSON, Scott D, SELCH, Michael, DOREY, Frederick, EILBER, Frederick R

    Published in Journal of clinical oncology (01-07-2001)
    “…To determine whether treatment-induced pathologic necrosis correlates with local recurrence and overall survival in patients who receive neoadjuvant therapy…”
    Get full text
    Journal Article
  3. 3

    Overexpression of miR-26a-2 in human liposarcoma is correlated with poor patient survival by Lee, D H, Amanat, S, Goff, C, Weiss, L M, Said, J W, Doan, N B, Sato-Otsubo, A, Ogawa, S, Forscher, C, Koeffler, H P

    Published in Oncogenesis (New York, NY) (01-05-2013)
    “…Approximately 90% of well-differentiated/de-differentiated liposarcomas (WDLPS/DDLPS), the most common LPS subtype, have chromosomal amplification at…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Immunotherapy of Advanced Malignancy by Direct Gene Transfer of an Interleukin-2 DNA/DMRIE/DOPE Lipid Complex: Phase I/II Experience by GALANIS, E, HERSH, E. M, FORSCHER, C, SONDAK, V. K, LEWIS, B. D, UNGER, E. C, O'DRISCOLL, M, SELK, L, RUBIN, J, STOPECK, A. T, GONZALEZ, R, BURCH, P, SPIER, C, AKPORIAYE, E. T, RINEHART, J. J, EDMONSON, J, SOBOL, R. E

    Published in Journal of clinical oncology (01-10-1999)
    “…We have completed a phase I study, followed by three phase I/II studies, in patients with metastatic melanoma, renal cell carcinoma (RCC), and sarcoma in order…”
    Get full text
    Journal Article
  6. 6

    Decomposing fear perception: A combination of psychophysics and neurometric modeling of fear perception by Forscher, Emily C., Zheng, Yan, Ke, Zijun, Folstein, Jonathan, Li, Wen

    Published in Neuropsychologia (01-10-2016)
    “…Emotion perception is known to involve multiple operations and waves of analysis, but specific nature of these processes remains poorly understood. Combining…”
    Get full text
    Journal Article
  7. 7

    Hemispheric asymmetry and visuo-olfactory integration in perceiving subthreshold (micro) fearful expressions by Forscher, Emily C, Li, Wen

    Published in The Journal of neuroscience (08-02-2012)
    “…Multisensory integration is ubiquitous, facilitating perception beyond the limit of individual senses. This mechanism is especially salient when individual…”
    Get full text
    Journal Article
  8. 8

    Aldoxorubicin: a tumor-targeted doxorubicin conjugate for relapsed or refractory soft tissue sarcomas by Gong, Jun, Yan, Jessica, Forscher, Charles, Hendifar, Andrew

    Published in Drug design, development and therapy (01-01-2018)
    “…Despite available therapies after initial systemic therapy, prognosis remains poor in relapsed or refractory soft tissue sarcomas (STS). The rational and…”
    Get full text
    Journal Article
  9. 9

    Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial by Gounder, Mrinal M, Razak, Albiruni Abdul, Somaiah, Neeta, Chawla, Sant, Martin-Broto, Javier, Grignani, Giovanni, Schuetze, Scott M, Vincenzi, Bruno, Wagner, Andrew J, Chmielowski, Bartosz, Jones, Robin L, Riedel, Richard F, Stacchiotti, Silvia, Loggers, Elizabeth T, Ganjoo, Kristen N, Le Cesne, Axel, Italiano, Antoine, Garcia Del Muro, Xavier, Burgess, Melissa, Piperno-Neumann, Sophie, Ryan, Christopher, Mulcahy, Mary F, Forscher, Charles, Penel, Nicolas, Okuno, Scott, Elias, Anthony, Hartner, Lee, Philip, Tony, Alcindor, Thierry, Kasper, Bernd, Reichardt, Peter, Lapeire, Lore, Blay, Jean-Yves, Chevreau, Christine, Valverde Morales, Claudia Maria, Schwartz, Gary K, Chen, James L, Deshpande, Hari, Davis, Elizabeth J, Nicholas, Garth, Gröschel, Stefan, Hatcher, Helen, Duffaud, Florence, Herráez, Antonio Casado, Beveridge, Roberto Diaz, Badalamenti, Giuseppe, Eriksson, Mikael, Meyer, Christian, von Mehren, Margaret, Van Tine, Brian A, Götze, Katharina, Mazzeo, Filomena, Yakobson, Alexander, Zick, Aviad, Lee, Alexander, Gonzalez, Anna Estival, Napolitano, Andrea, Dickson, Mark A, Michel, Dayana, Meng, Changting, Li, Lingling, Liu, Jianjun, Ben-Shahar, Osnat, Van Domelen, Dane R, Walker, Christopher J, Chang, Hua, Landesman, Yosef, Shah, Jatin J, Shacham, Sharon, Kauffman, Michael G, Attia, Steven

    Published in Journal of clinical oncology (01-08-2022)
    “…Antitumor activity in preclinical models and a phase I study of patients with dedifferentiated liposarcoma (DD-LPS) was observed with selinexor. We evaluated…”
    Get full text
    Journal Article
  10. 10

    Surgical indications for Ewing's sarcoma of the pelvis by Yang, R S, Eckardt, J J, Eilber, F R, Rosen, G, Forscher, C A, Dorey, F J, Kelly, C M, al-Shaikh, R

    Published in Cancer (15-10-1995)
    “…Despite advances in adjuvant therapy, Ewing's sarcoma of the pelvis remains an anatomic site with a poor prognosis. This study evaluate the role of surgery in…”
    Get more information
    Journal Article
  11. 11

    Preoperative therapy for soft tissue sarcoma by Eilber, F, Eckardt, J, Rosen, G, Forscher, C, Selch, M, Fu, Y S

    “…Soft tissue sarcomas appear to be an ideal tumor type for delivering preoperative therapy. The rationale for preoperative therapy is that it is delivered to…”
    Get more information
    Journal Article
  12. 12

    Successful treatment of metastatic small cell carcinoma of the bladder with methotrexate, vinblastine, doxorubicin and cisplatin therapy by Cheng, D L, Unger, P, Forscher, C A, Fine, E M

    Published in The Journal of urology (01-02-1995)
    “…A man with metastatic small cell carcinoma of the bladder who was treated with methotrexate, vinblastine, doxorubicin and cisplatin therapy achieved complete…”
    Get more information
    Journal Article
  13. 13

    High grade soft tissue sarcoma of the flexor fossae. Size rather than compartmental status determine prognosis by Yang, R S, Lane, J M, Eilber, F R, Dorey, F J, al-Shaikh, R, Schumacher, L Y, Rosen, G, Forscher, C A, Eckardt, J J

    Published in Cancer (15-10-1995)
    “…High grade soft tissue sarcoma arising in the popliteal space, axilla, and antecubital fossae (flexor fossae tumors) have by convention been classified as…”
    Get more information
    Journal Article
  14. 14

    Targeted therapy for sarcomas by Forscher, Charles, Mita, Monica, Figlin, Robert

    Published in Biologics (01-01-2014)
    “…Overviews the development of targeted agents for sarcomas, tumours of mesenchymal origin arising in either bone or soft tissue that make up approximately 1% of…”
    Get full text
    Journal Article
  15. 15

    Pseudothrombocytopenia masking true thrombocytopenia by Forscher, C A, Sussman, I I, Friedman, E W, Solomon, V, Spaet, T H

    Published in American journal of hematology (01-03-1985)
    “…Pseudothrombocytopenia owing to platelet clumping is usually associated with blood specimens anticoagulated with EDTA. It may also be seen if specimens…”
    Get more information
    Journal Article
  16. 16
  17. 17

    Sub-aggregatory doses of catecholamines prevent prostacyclin-induced inhibition of platelet aggregation by Buttrick, P M, Forscher, C A, Sussman, I I, Mueller, H S

    Published in The American heart journal (01-06-1985)
    “…To assess the effect of subaggregatory concentrations of catecholamines on the antiaggregatory effect of prostacyclin (PGI2), platelets from normal human…”
    Get more information
    Journal Article
  18. 18

    Synovial sarcoma. Uniform response of metastases to high dose ifosfamide by Rosen, G, Forscher, C, Lowenbraun, S, Eilber, F, Eckardt, J, Holmes, C, Fu, Y S

    Published in Cancer (15-05-1994)
    “…This report describes the unusually high response rate of metastatic synovial sarcoma to high dose ifosfamide (14-18 g/m2) when that drug was used to treat 13…”
    Get more information
    Journal Article
  19. 19

    Surgical resection and intraperitoneal chemotherapy for recurrent abdominal sarcomas by Eilber, F C, Rosen, G, Forscher, C, Nelson, S D, Dorey, F J, Eilber, F R

    Published in Annals of surgical oncology (01-10-1999)
    “…Recurrent abdominal sarcomas have an extremely high rate of recurrence and poor overall survival. A prospective study was initiated to assess the feasibility,…”
    Get full text
    Journal Article
  20. 20